The MUSC Hematology & Oncology Fellowship Program began in 1986 and is the only hematology/oncology training program in the state of South Carolina. The program currently accepts four trainees into each class for the three-year combined hematology/oncology training. This program provides extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation. Training in the basic principles and practice of hematology/oncology is provided to all fellows and additional training in basic and/or clinical research is available.
The Hematology & Oncology Fellowship is fully integrated with the clinical and translational research programs at MUSC's Hollings Cancer Center , allowing the opportunity for laboratory experiences, collaborative engagement, and participation in translational medicine. Fellows are expected to participate in the clinical and laboratory research activities and opportunities provided by the Cancer Center. The Hollings Cancer Center is a National Cancer Institute (NCI)-designated cancer center.
The program only accepts July 1 matriculates. The applications for matriculation are accepted only through the AAMC's ERAS system, and all applications for matriculation should be completed no later than July 31 in the year prior in order to be considered. Interview dates are typically in the fall. Applicants must be considered actively board-certified or board-eligible in internal medicine by the American Board of Internal Medicine or presently be in an internal medicine training program leading to such certification. Candidates who have passed the USMLE Step 3 exam are preferred, as passage of Step 3 is an institutional requirement for fellowship matriculation.
Sponsor Institute/Organizations: Medical University of South Carolina
Sponsor Type:
Address: 171 Ashley Avenue, Charleston, SC 29425
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jul 31, 2025
Jul 31, 2025
Varies
Affiliation: Medical University of South Carolina
Address: 171 Ashley Avenue, Charleston, SC 29425
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.